Regenerative Medicine Market by technology, Material and Application - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

  • ID: 3773501
  • Report
  • Region: Global
  • 145 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • Acelity Holdings
  • Baxter International Inc.
  • CryoLife Inc.
  • DePuy Synthes
  • Medtronic plc
  • Stryker Corporation
  • MORE
Regenerative medicines hold the ability to replace, repair, and regenerate tissues and organs that are affected due to some disease, injury, or natural ageing process. These medicines are capable of restoring the functionality of tissues & cells applicable in a wide range of degenerative disorders such as neurodegenerative diseases, dermatology, cardiovascular and orthopedic applications. Researchers have been focusing on the development of advanced technologies based on genes, biologics, somatic cells and stem cells. Stem cells have the capability to proliferate and differentiate owing to which they are of importance in this field. Currently, predominant treatments available for degenerative or life-threatening diseases do not provide a treatment or are palliative; however, regenerative medicines have the ability to replace or regenerate the tissues and organs suffering from injury or disease. Moreover, the exploitation of nano-materials in drug delivery, wound care and immunomodulation are opportunistic for the regenerative medicine market.

The growth of this market is attributed by the factors such as an emergence of stem cell technology, valuable potential of nanotechnology, rising prevalence of chronic diseases & trauma emergencies, innovation in monitoring devices and surgical technologies. Moreover, rising incidence of degenerative diseases specifically and shortage for organ transplants has boosted the market growth. Furthermore, the increasing focus on stem cells with new source, and getting core competency in the emerging economies are expected to supplement the growth in future. The developing nations are adopting technological advanced treatment modalities at a rapid pace, which is expected to assist in the market expansion worldwide. However, operational inefficiency, stringent regulations, and the high cost of the treatment through regenerative medicine deters the market progression.

The report segments the world regenerative medicine market based on product type, material, application, and geography. Based on product type, it is categorized into cell therapy, gene therapy, tissue engineering, and small molecules & biologics. Cell therapy dominated the market among all other products owing to its efficiency to restore the lost function of any tissue or organ. However, the small molecules & biologics segment is anticipated to grow at a highest CAGR of 34.2% from 2016 to 2022, due to its potential to stimulate dormant or endogenous cells to regain their regenerative properties.

Based on material, the market is classified into synthetic materials, biologically derived materials, genetically engineered materials, and pharmaceuticals. The world regenerative medicine market is expected to reach $30,237 million by 2022 at a CAGR of 33.1% during 2016-2022. These materials are further subcategorized into different segments. The biologically derived materials accounted for about 4/7th of total market share in 2015, and is estimated to retain its position during the analysis period. The increasing demand for genetically engineered materials specially due to their unique properties such as promotion of increased proliferation, cellular interactions, and differentiation of cells that facilitates self-assembly into organized structures, and controlling the manipulation of cellular behavior.

On the basis of application, Regenerative medicine market is segmented as cardiovascular, oncology, dermatology, musculoskeletal, wound healing, ophthalmology, neurology, and others. The musculoskeletal application accounted for the largest share in 2015, whereas cardiovascular is expected to be the fastest growing segment at a CAGR of 35.3% during the analysis period.

Geographically, the market is divided into North America, Europe, Asia-Pacific, and LAMEA regions. North America is projected to dominate the overall market owing to the rising incidence of chronic disorders, growing demand for artificial organs due to the rise in the cases of organ failure, and presence of highly sophisticated healthcare infrastructure. Asia-Pacific is projected to emerge as the region with maximum growth potential, with a CAGR of 39.9% during the forecast period, due to the presence of high unmet medical needs and persistently improving healthcare infrastructure. In addition, chief countries such as India, China, Australia and Japan contribute to the market growth due to high population base, rising demand for tissue-engineered and regenerative medicine products. These countries have varying demographic and cultural conditions, which highly influence their respective markets.

Key players operating in the regenerative medicine market include Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic plc, Baxter International Inc., DePuy Synthes, Organogenesis Inc. (Advanced Biohealing), Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., Ocata Therapeutics Inc. (Astellas Pharma Inc.), and CryoLife Inc.

Key Benefits
- The report includes an extensive analysis of the factors driving as well as restraining the world regenerative medicine market.
- The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
- The report provides a quantitative analysis from 2014 to 2022 that is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Extensive analysis by product, material, application, and geography helps in understanding the various types of devices used for different chronic abnormalities.
- Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.

Key Market Segments:

BY TECHNOLOGY
 Cell Therapy
 Gene Therapy
 Tissue Engineering
 Small Molecules & Biologics

BY MATERIAL

- Synthetic Materials
 Biodegradable Synthetic Polymers
 Scaffold
 Artificial Vascular Graft Materials
 Hydrogel Material

- Biologically Derived Materials
 Collagen
 Xenogeneic Material

- Genetically Engineered Materials
 Deoxyribonucleic Acid Transfection Vectors
 Genetically Manipulated Cells
 Three-Dimensional Polymer Technology
 Transgenic
 Fibroblasts
 Neural Stem Cells
 Gene-Activated Matrices

- Pharmaceuticals
 Small Molecules
 Biologics

BY APPLICATION
 Cardiovascular
 Oncology
 Dermatology
 Musculoskeletal
 Wound Healing
 Ophthalmology
 Neurology
 Others

BY GEOGRAPHY
- North America
 U.S.
 Canada
 Mexico

- Europe
 Germany
 UK
 France
 Italy
 Spain
 Russia
 Rest of Europe

- Asia-Pacific
 Japan
 China
 India
 Australia
 South Korea
 Taiwan
 Rest of Asia-Pacific

- LAMEA
 Brazil
 Turkey
 Venezuela
 Saudi Arabia
 Republic of South Africa
 Rest of LAMEA
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Acelity Holdings
  • Baxter International Inc.
  • CryoLife Inc.
  • DePuy Synthes
  • Medtronic plc
  • Stryker Corporation
  • MORE
Chapter: 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

EXECUTIVE SUMMARY
2.1 CXO perspective

Chapter: 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Competitive rivalry
3.3.5 Treat of substitutes

3.4 Market dynamics

3.4.1 Drivers

3.4.1.1 High adoption of Stem cell technology
3.4.1.2 Emerging application of nanotechnology
3.4.1.3 Increasing prevalence of chronic diseases and trauma emergencies
3.4.1.4 Advancements in Medical Equipment technologies

3.4.2 Restraints

3.4.2.1 Complex regeneration processes
3.4.2.2 Costly treatment Associated with regenerative medicne

3.4.3 Opportunities

3.4.3.1 Lucrative opportunities of novel stem cell technologies
3.4.3.2 Increasing potential in emerging economies
3.4.3.3 Growing need of regenerative medicine in organ transplantation

Chapter: 4 WORLD REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2015-2022
4.1 Overview

4.1.1 Market size and forecast

4.2 Cell therapy

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 Gene therapy

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 Tissue Engineering

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

4.5 Small molecules and biologics

4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast

$1251(SU)
Chapter: 5 WORLD REGENERATIVE MEDICINE MARKET, BY MATERIAL, 2015-2022
5.1 Overview

5.1.1 Market size and forecast

5.2 Synthetic materials

5.2.1 Market size and forecast
5.2.2 Biodegradable synthetic polymers

5.2.2.1 Market size and forecast

5.2.3 Scaffold

5.2.3.1 Market size and forecast

5.2.4 Artificial vascular graft materials

5.2.4.1 Market size and forecast

5.2.5 Hydrogel material

5.2.5.1 Market size and forecast

5.3 Biologically derived materials

5.3.1 Market size and forecast
5.3.2 Collagen

5.3.2.1 Market size and forecast

5.3.3 Xenogeneic material

5.3.3.1 Market size and forecast

5.4 Genetically Engineered Materials

5.4.1 Market size and forecast
5.4.2 Deoxyribonucleic Acid Transfection Vectors

5.4.2.1 Market size and forecast

5.4.3 Genetically manipulated cells

5.4.3.1 Market size and forecast

5.4.4 Three-dimensional polymer technology

5.4.4.1 Market size and forecast

5.4.5 Transgenic

5.4.5.1 Market size and forecast

5.4.6 Fibroblasts

5.4.6.1 Market size and forecast

5.4.7 Neural stem cells

5.4.7.1 Market size and forecast

5.4.8 Gene-activated matrices

5.4.8.1 Market size and forecast

5.5 Pharmaceuticals

5.5.1 Market size and forecast
5.5.2 Small molecules

5.5.2.1 Market size and forecast

5.5.3 Biologics

5.5.3.1 Market size and forecast

Chapter: 6 WORLD REGENERATIVE MEDICINE MARKET, BY APPLICATION, 2015-2022
6.1 Overview

6.1.1 Market size and forecast

6.2 Cardiovascular

6.2.1 Market size and forecast

6.3 Oncology

6.3.1 Market size and forecast

6.4 Dermatology

6.4.1 Market size and forecast

6.5 Musculoskeletal

6.5.1 Market size and forecast

6.6 Wound healing

6.6.1 Market size and forecast

6.7 Ophthalmology

6.7.1 Market size and forecast

6.8 Neurology

6.8.1 Market size and forecast

6.9 Other

6.9.1 Market size and forecast

Chapter: 7 WORLD REGENERATIVE MEDICINE MARKET, BY GEOGRAPHY, 2015-2022
7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.2.4 U.S.

7.2.4.1 Market size and forecast

7.2.5 Canada

7.2.5.1 Market size and forecast

7.2.6 Mexico

7.2.6.1 Market size and forecast

7.3 Europe

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.3.4 Germany

7.3.4.1 Market size and forecast

7.3.5 France

7.3.5.1 Market size and forecast

7.3.6 U.K.

7.3.6.1 Market size and forecast

7.3.7 Italy

7.3.7.1 Market size and forecast

7.3.8 Spain

7.3.8.1 Market size and forecast

7.3.9 Russia

7.3.9.1 Market size and forecast

7.3.10 Rest of Europe

7.3.10.1 Market size and forecast

7.4 Asia-Pacific

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
7.4.4 Japan

7.4.4.1 Market size and forecast

7.4.5 China

7.4.5.1 Market size and forecast

7.4.6 Australia

7.4.6.1 Market size and forecast

7.4.7 India

7.4.7.1 Market size and forecast

7.4.8 South Korea

7.4.8.1 Market size and forecast

7.4.9 Taiwan

7.4.9.1 Market size and forecast

7.4.10 Rest of Asia-Pacific

7.4.10.1 Market size and forecast

7.5 LAMEA

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast
7.5.4 Brazil

7.5.4.1 Market size and forecast

7.5.5 Turkey

7.5.5.1 Market size and forecast

7.5.6 Venezuela

7.5.6.1 Market size and forecast

7.5.7 Saudi Arabia

7.5.7.1 Market size and forecast

7.5.8 Republic of South Africa

7.5.8.1 Market size and forecast

7.5.9 Others LAMEA

7.5.9.1 Market size and forecast

Chapter: 8 COMPANY PROFILES
8.1 Integra Lifesciences Corporation

8.1.1 Company overview
8.1.2 Operating business segments
8.1.3 Business performance
8.1.4 Key strategic moves and developments

8.2 Stryker Corporation

8.2.1 Company overview
8.2.2 Operating business segments
8.2.3 Business performance
8.2.4 Key strategic moves and developments

8.3 Acelity Holdings, Inc. (LifeCell Corporation)

8.3.1 Company overview
8.3.2 Operating business segments
8.3.3 Business performance
8.3.4 Key strategic moves and developments

8.4 Organogenesis Inc. (Advanced Biohealing)

8.4.1 Company overview
8.4.2 Operating business segments
8.4.3 Key strategic moves and developments

8.5 Arteriocyte Medical Systems, Inc.

8.5.1 Company overview
8.5.2 Operating business segments
8.5.3 Key strategic moves and developments

8.6 Athersys, Inc.

8.6.1 Company overview
8.6.2 Operating business segments
8.6.3 Business performance
8.6.4 Key strategic moves and developments

8.7 U.S. Stem Cell, Inc. (Bioheart, Inc.)

8.7.1 Company overview
8.7.2 Operating business segments
8.7.3 Business performance
8.7.4 Key strategic moves and developments

8.8 Zimmer Biomet Holdings, Inc. (Zimmer)

8.8.1 Company overview
8.8.2 Operating business segments
8.8.3 Business performance
8.8.4 Key strategic moves and developments

8.9 CryoLife, Inc.

8.9.1 Company overview
8.9.2 Operating business segments
8.9.3 Business performance
8.9.4 Key strategic moves and developments

8.10 Medtronic plc

8.10.1 Company overview
8.10.2 Operating business segments
8.10.3 Business performance
8.10.4 Key strategic moves and developments

List Of Tables

Table 1 Unintentional Injuries Facts (2013)
Table 2 Trends In Regenerative Medicine Industry (2007-2011)
Table 3 World Regenerative Medicine Market, By Product Type, 2015-2022 ($Million)
Table 4 World Regenerative Medicine Market For Cell Therapy, By Geography, 2015-2022 ($Million)
Table 5 World Regenerative Medicine Market For Gene Therapy, By Geography, 2015-2022 ($Million)
Table 6 World Regenerative Medicine Market For Tissue Engineering, By Geography, 2015-2022 ($Million)
Table 7 World Regenerative Medicine Market For Small Molecules And Biologics, By Geography, 2015-2022 ($Million)
Table 8 World Regenerative Medicine Market, By Material, 2015-2022 ($Million)
Table 9 World Regenrative Medicine Market For Synthetic Materials, 2015-2022 ($Million)
Table 10 World Synthetic Material Market, By Geography, 2015-2022 ($Million)
Table 11 Classification Of Biodegradable Polymers
Table 12 World Biodegradable Synthetic Polymers Market, By Geography, 2015-2022 ($Million)
Table 13 List Of Commercial Polymeric Scaffolds Products
Table 14 World Scaffold Market, By Geography, 2015-2022 ($Million)
Table 15 World Artificial Vascular Graft Materials Market, By Geography, 2015-2022 ($Million)
Table 16 World Hydrogel Material Market, By Geography, 2015-2022 ($Million)
Table 17 World Regenerative Medicine Market For Biologically Derived Materials, 2015-2022 ($Million)
Table 18 World Biologically Derived Materials Market, By Geography, 2015-2022 ($Million)
Table 19 World Collagen Market, By Geography, 2015-2022 ($Million)
Table 20 World Xenogeneic Material Market, By Geography, 2015-2022 ($Million)
Table 21 World Regenerative Medicine Market For Genetically Engineered Materials, 2015-2022 ($Million)
Table 22 World Genetically Engineered Materials Market, By Geography, 2015-2022 ($Million)
Table 23 World Deoxyribonucleic Acid Transfection Vectors Market, By Geography, 2015-2022 ($Million)
Table 24 World Genetically Manipulated Cells Market, By Geography, 2015-2022 ($Million)
Table 25 World Three-Dimensional Polymer Technology Market, By Geography, 2015-2022 ($Million)
Table 26 World Transgenic Market, By Geography, 2015-2022 ($Million)
Table 27 World Fibroblasts Market, By Geography, 2015-2022 ($Million)
Table 28 World Neural Stem Cells Market, By Geography, 2015-2022 ($Million)
Table 29 World Gene-Activated Matrices Market, By Geography, 2015-2022 ($Million)
Table 30 World Regenerative Medicine Market For Pharmaceuticals, 2015-2022 ($Million)
Table 31 World Pharmaceuticals Market, By Geography, 2015-2022 ($Million)
Table 32 World Regenerative Medicine Market, By Application, 2015-2022 ($Million)
Table 33 World Cardiovascular Application Market, By Geography, 2015-2022 ($Million)
Table 34 World Oncology Application Market, By Geography, 2015-2022 ($Million)
Table 35 Statistics For Skin Damage Medical Conditions In The U.S. And Worldwide, 2011
Table 36 List Of Acellular Skin Tissue-Engineered Products In The Market
Table 37 List Of Cellular Skin Tissue-Engineered Products In The Market
Table 38 World Dermatology Application Market, By Geography, 2015-2022 ($Million)
Table 39 Statistics For Bone Damage And Related Diseases, 2011
Table 40 Statistics For Cartilage Damage Worldwide
Table 41 World Musculoskeletal Application Market, By Geography, 2015-2022 ($Million)
Table 42 World Wound Healing Application Market, By Geography, 2015-2022 ($Million)
Table 43 World Ophthalmology Application Market, By Geography, 2015-2022 ($Million)
Table 44 World Neurology Application Market, By Geography, 2015-2022 ($Million)
Table 45 World Other Application Market, By Geography, 2015-2022 ($Million)
Table 46 World Regenerative Medicine Market, By Geography, 2015-2022 ($Million)
Table 47 North America Regenerative Medicine Market, By Product Type, 2015-2022 ($Million)
Table 48 North America Regenerative Medicine Market, By Country, 2015-2022 ($Million)
Table 49 European Regenerative Medicine Market, By Product Type, 2015-2022 ($Million)
Table 50 European Regenerative Medicine Market, By Country, 2015-2022 ($Million)
Table 51 Asiapacific Regenerative Medicine Market, By Product Type, 2015-2022 ($Million)
Table 52 Asia-Pacific Regenerative Medicine Market, By Country, 2015-2022 ($Million)
Table 53 Lamea Regenerative Medicine Market, By Product Type, 2015-2022 ($Million)
Table 54 Lamea Regenerative Medicine Market, By Country, 2015-2022 ($Million)
Table 55 Integra Lifesciences: Company Snapshot
Table 56 Integra Lifesciences: Operating Segments
Table 57 Stryker: Company Snapshot
Table 58 Stryker: Operating Segments
Table 59 Acelity: Company Snapshot
Table 60 Acelity: Operating Segments
Table 61 Organogenesis: Company Snapshot
Table 62 Organogenesis, Inc.: Product Segment
Table 63 Arteriocyte: Company Snapshot
Table 64 Arteriocyte: Operating Segment
Table 65 Athersys: Company Snapshot
Table 66 Athersys: Operating Segments
Table 67 Us Stem Cell: Company Snapshot
Table 68 Zimmer Biomet: Company Snapshot
Table 69 Zimmer Biomet: Operating Segments
Table 70 Cryolife: Company Snapshot
Table 71 Cryolife: Operating Segments
Table 72 Medtronic: Company Snapshot
Table 73 Medtronic: Operating Segments

List Of Figures

Fig. 1 Top Investment Pockets In World Regenerative Medicine Market
Fig. 2 Top Winning Strategies: Percentage Distribution, (2014-2016)
Fig. 3 Porters Five Forces Analysis
Fig. 4 Top Impacting Factors: World Regenerative Medicine Market
Fig. 5 Growth In Disease Treated Vs. Clinical Trials (2008-2012)
Fig. 6 World Regenerative Medicine Market For Small Molecules, 2015-2022 ($Million)
Fig. 7 World Regenerative Medicine Market For Biologics, 2015-2022 ($Million)
Fig. 8 U.S. Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 9 Canada Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 10 Mexico Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 11 Germany Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 12 France Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 13 Uk Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 14 Italy Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 15 Spain Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 16 Russian Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 17 Rest Of Europe Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 18 Japan Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 19 China Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 20 Australia Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 21 Indian Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 22 South Korea Regenerative Medicine Market, 2015-2022 ($Million
Fig. 23 Taiwan Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 24 Rest Of Asia-Pacific Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 25 Brazil Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 26 Turkey Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 27 Venezuela Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 28 Saudi Arabia Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 29 Republic Of South Africa Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 30 Other Regenerative Medicine Market, 2015-2022 ($Million)
Fig. 31 Integra Lifesciences: Revenue, 2013-2015 ($Million)
Fig. 32 Integra Lifesciences: Revenue, By Segment, 2015 (%)
Fig. 33 Integra Lifesciences: Revenue, By Geography, 2015 (%)
Fig. 34 Stryker Corporation: Revenue, 2013-2015 ($Million)
Fig. 35 Stryker Corporation: Revenue, By Segment, 2015 (%)
Fig. 36 Stryker Corporation: Revenue, By Geography, 2015 (%)
Fig. 37 Acelity: Revenue, 2013-2015 ($Million)
Fig. 38 Acelity: Revenue, By Segment, 2015 (%)
Fig. 39 Acelity: Revenue, By Geography, 2015 (%)
Fig. 40 Athersys: Revenue, 2013-2015 ($Million)
Fig. 41 Us Stem Cell: Revenue, 2013-2015 ($Million)
Fig. 42 Zimmer Biomet: Revenue, 2013-2015 ($Million)
Fig. 43 Zimmer Biomet: Revenue, By Segment, 2015 (%)
Fig. 44 Zimmer Biomet: Revenue, By Geography, 2015 (%)
Fig. 45 Cryolife: Revenue, 2013-2015 ($Million)
Fig. 47 Cryolife: Revenue, By Geography, 2015 (%)
Fig. 48 Medtronic: Revenue, 2013-2015 ($Million)
Fig. 49 Medtronic: Revenue, By Segment, 2015 (%)
Fig. 50 Medtronic: Revenue, By Geography, 2015 (%)
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Acelity Holdings
  • Baxter International Inc.
  • CryoLife Inc.
  • DePuy Synthes
  • Medtronic plc
  • Stryker Corporation
  • MORE
A new report titled, "Regenerative Medicine Market- Global Opportunity Analysis and Industry Forecast, 2014 - 2022", projects that the global regenerative medicine market would reach $30,237 million by 2022. Cell therapy segment is expected to dominate the market throughout the forecast period. North America led the global market in 2015, and is expected to remain dominant during the 2015-2022.

Major factors boosting the market growth include technological advancements in tissue & organ regeneration, increase in prevalence of chronic diseases & trauma emergencies, prominent potential of nanotechnology, and emergence of stem cell technology. In addition, increase in incidence of degenerative diseases and limited availability of organs for transplants are expected to boost the market growth. The ability of regenerative medicine to replace, repair, and regenerate damaged tissues & organs stimulated the market growth.

The utilization of nano-materials in wound care, drug delivery, and immunomodulation would create new growth opportunities for the market. However, stringent regulations, operational inefficiency, lack of awareness about tissue engineering & regenerative medicine-based products and high cost restricts its growth. An in-house analyst states, Advancements in stem cell technology and growing demand of regenerative medicine in the emerging economies would fuel the market growth. In addition, the developed nations are adopting technological advancements in tissue engineering and regenerative medicine field at a rapid pace, which is expected to aid market expansion worldwide.

The cell therapy segment accounted for over three-fifths of the overall regenerative medicine market in 2015. This was due to the wide adoption of cell therapy for the treatment of several diseases such as musculoskeletal, cardiovascular, oncology, wound healing, and others. Small molecules & biologics has emerged as the fastest growing segment and is projected to register a CAGR of 34.2% during the forecast period. This is due to biologics, which is a classic active substance, delivering a better overall economic return. These molecules have revolutionized the treatment of specific diseases such as cancer, musculoskeletal diseases, rheumatoid arthritis, and non-healing wounds.

Biologically derived materials, such as collagen and xenogeneic, are majorly applicable in the construction of protein membranes in connective tissues, surgical procedures for valvular diseases, liver tissue engineering, construction of biopolymer scaffolds for tissue engineering, and others. The growing demand for these biologically derived materials further boosts the market growth. The biologically derived material segment accounted for the major share in 2015, whereas, the synthetic material is expected to grow at a significant CAGR of 35.5% during the forecast period.

Geographically, North America accounted for the majority of the market share in 2015, and is expected to maintain its lead throughout. This is attributed to the presence of higher capital investment, high disposable income of patients (increasing the buying potential), rise in clinical studies, and favorable government policies for the commercialization of tissue engineering and regenerative medicine products. However, Asia-Pacific is projected to be the fastest growing region, owing to the improving healthcare infrastructure and healthcare expenditures in the emerging markets (such as India and China) to overcome the unmet medical needs. In addition, tissue engineering and regenerative medicine market is growing substantially due to the increasing incidence of accidental trauma injuries in this region. Increasing incidences of injuries and the ageing population also contributes to the market growth.

Key findings of Regenerative Medicines Market:
Biologically derived materials led the market, accounting for almost four-sevenths of the overall market revenue in 2015, and is projected to grow at a CAGR of 31.6% during the forecast period.
Scaffold in synthetic material segment is expected to grow at a CAGR of 42.4%, owing to the degradation properties and bioabsorbable polymer, which acts as a bone fixation device.
U.S. is projected to maintain its lead in the regenerative medicine market until 2022.
Musculoskeletal and wound healing applications together accounted for around 60% of the overall market shares in 2015.
China and Japan are the major shareholders, jointly accounting for almost two-thirds in the Asia-Pacific market.
The collagen segment constitutes a major share of the biologically derived materials market.
Three-dimensional polymer technology is anticipated to grow at fastest rate, with a CAGR of 44% from 2016 to 2022.

Key players in the regenerative medicine market are highly focused on expanding their business operations in the emerging countries with new product launches as a preferred strategy. Leading players profiled in the report include Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic plc, Baxter International Inc., DePuy Synthes, Organogenesis Inc. (Advanced Biohealing), Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., Ocata Therapeutics Inc. (Astellas Pharma Inc.), and CryoLife Inc.
Note: Product cover images may vary from those shown
5 of 5
- Stryker Corporation
- Zimmer Biomet Holdings
- Medtronic plc
- Baxter International Inc.
- DePuy Synthes
- Organogenesis Inc. (Advanced Biohealing)
- Integra Lifesciences Holdings Corporation
- Acelity Holdings
- Ocata Therapeutics Inc. (Astellas Pharma Inc.)
- CryoLife Inc.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll